These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24554750)

  • 21. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods.
    Daly CC; Hoffman I; Hobbs M; Maida M; Zimba D; Davis R; Mughogho G; Cohen MS
    J Clin Microbiol; 1997 Nov; 35(11):2985-8. PubMed ID: 9350775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the in vitro susceptibility of Neisseria gonorrhoeae isolates from 8 cities in Guangdong Province through an improved microdilution method.
    Wu X; Qin X; Huang J; Wang F; Li M; Wu Z; Liu X; Pei J; Wu S; Chen H; Guo C; Xue Y; Tang S; Fang M; Lan Y; Ou J; Xie Z; Yu Y; Yang J; Chen W; Zhao Y; Zheng H
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):325-331. PubMed ID: 30292397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates.
    Liu YH; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2018 May; 51(5):768-774. PubMed ID: 29477549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Etest for testing antimicrobial susceptibilities of Neisseria gonorrhoeae isolates with different growth media.
    Yeung KH; Ng LK; Dillon JA
    J Clin Microbiol; 1993 Nov; 31(11):3053-5. PubMed ID: 8263199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
    Jones RN; Barrett MS; Deguchi T
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):193-200. PubMed ID: 9327248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
    Jönsson A; Jacobsson S; Foerster S; Cole MJ; Unemo M
    APMIS; 2018 Oct; 126(10):822-827. PubMed ID: 30191618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.
    Lee H; Hong SG; Soe Y; Yong D; Jeong SH; Lee K; Chong Y
    Sex Transm Dis; 2011 Nov; 38(11):1082-6. PubMed ID: 21992988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing of
    Gianecini R; Irazu L; Rodríguez M; Cristaldo P; Oviedo C; Turco M; Rodrigo V; Canigia LF; Schneider A; Guelfand L; Scocozza L; ; Galarza P
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32817227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.
    Limnios A; Tapsall J; Kahlmeter J; Hogan T; Ray S; Lam A; Unemo M
    APMIS; 2011 Jun; 119(6):356-63. PubMed ID: 21569093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
    Kovari H; de Melo Oliveira MD; Hauser P; Läuchli S; Meyer J; Weber R; Zbinden R
    BMC Infect Dis; 2013 Dec; 13():603. PubMed ID: 24369054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.
    Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD
    BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010.
    Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Lovgren M; Haldane D; Caeseele PV; Horsman G; Garceau R; Ratnam S; Wong T; Gilmour M
    Can J Microbiol; 2013 Oct; 59(10):671-8. PubMed ID: 24102220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.
    Barbee LA; Soge OO; Holmes KK; Golden MR
    J Antimicrob Chemother; 2014 Jun; 69(6):1572-8. PubMed ID: 24468865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.
    Yasuda M; Hatazaki K; Ito S; Kitanohara M; Yoh M; Kojima M; Narita H; Kido A; Miyata K; Deguch T
    Sex Transm Dis; 2017 Mar; 44(3):149-153. PubMed ID: 28178112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.
    Carannante A; Prignano G; Cusini M; Matteelli A; Dal Conte I; Ghisetti V; D'Antuono A; Cavrini F; Antonetti R; Stefanelli P
    Clin Microbiol Infect; 2012 Jun; 18(6):558-64. PubMed ID: 21966997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012.
    Yu RX; Yin Y; Dai XQ; Chen SC; Han Y; Zheng BJ; Zhang GY; Chen XS
    Sex Transm Dis; 2017 Apr; 44(4):197-201. PubMed ID: 28282644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.